REGENXBIO INC.

Profile

Company Names

REGENXBIO INC.
REGENX BIOSCIENCES, LLC

Addresses

9712 MEDICAL CENTER DRIVE, SUITE 100, ROCKVILLE, MD 20850

1701 PENNSYLVANIA AVE, NW, SUITE 900, WASHINGTON, DC 20006

750 17TH STREET NW, SUITE 1100, WASHINGTON, DC 20006

Phone Numbers

240-552-8181
202-785-7438

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$105,891,885.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2015-05-15 
$70,500,008.00 
$70,500,008.00 
$0.00 
Equity 
2
2015-01-13 
$27,500,002.00 
$30,000,000.00 
$2,499,998.00 
Equity 
1
2013-10-30 
$7,891,875.00 
$7,891,875.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
BENJAMIN 
 
AUSPITZ 
DIRECTOR
REGENXBIO INC.   |  DIMENSION THERAPEUTICS, INC.   |  AKRIVEIA THERAPEUTICS, LLC
LUKE 
 
BESHAR 
DIRECTOR
REGENXBIO INC.   |  TRILLIUM THERAPEUTICS INC.
ALLAN 
 
FOX 
DIRECTOR
REGENX BIOSCIENCES, LLC   |  DIMENSION THERAPEUTICS, INC.   |  WINDMIL THERAPEUTICS, INC.   |  NEUROMOTION INC.
ALLAN 
M. 
FOX 
DIRECTOR
REGENXBIO INC.   |  FOXKISER VENTURES IV, LLC   |  FOXKISER VENTURES IV-B, LLC
DON 
 
HAYDEN 
DIRECTOR
REGENX BIOSCIENCES, LLC
DONALD 
J. 
HAYDEN, JR. 
DIRECTOR
NORA THERAPEUTICS, INC.   |  AMICUS THERAPEUTICS INC   |  REGENXBIO INC.   |  DIMENSION THERAPEUTICS, INC.   |  WINDMIL THERAPEUTICS, INC.
DANIEL 
 
KISER 
DIRECTOR
REGENX BIOSCIENCES, LLC
JOHN 
DANIEL 
KISER 
DIRECTOR
REGENXBIO INC.   |  FOXKISER VENTURES IV, LLC   |  FOXKISER VENTURES IV-B, LLC
KENNETH 
T. 
MILLS 
EXECUTIVE OFFICER, DIRECTOR
REGENX BIOSCIENCES, LLC   |  REGENXBIO INC.
CAMILLE 
 
SAMUELS 
DIRECTOR
SEMPRAE LABORATORIES INC   |  KYTHERA BIOPHARMACEUTICALS INC   |  ACHAOGEN INC   |  SPIROX, INC.   |  REGENXBIO INC.   |  UNITY BIOTECHNOLOGY, INC.   |  BIOLUX RESEARCH HOLDINGS, INC.   |  XCALIBER BIOTECHNOLOGY, INC.   |  OCELOT BIO, INC.   |  MAHZI THERAPEUTICS INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2015-05-28
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-05-15 
2015-01-23
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-01-13 
2013-11-07
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-10-30 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
CHARDAN CAPITAL MARKETS, LLC
120128
CHARDAN CAPITAL MARKETS, LLC
120128